STILBENE COMPOUNDS FOR USE IN THE TREATMENT OF TUMOUR AND EYE DISEASES

Provided is the use of stilbene compounds in the preparation of anti-tumor medicaments, and related is the pharmaceutical field. The stilbene compounds of the present invention are compounds represented by formula I, or salts thereof, or stereoisomers thereof, or solvates thereof. In the present inv...

Full description

Saved in:
Bibliographic Details
Main Author YONG, Zhiquan
Format Patent
LanguageEnglish
French
German
Published 27.03.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Provided is the use of stilbene compounds in the preparation of anti-tumor medicaments, and related is the pharmaceutical field. The stilbene compounds of the present invention are compounds represented by formula I, or salts thereof, or stereoisomers thereof, or solvates thereof. In the present invention, it is discovered that stilbene compounds have a dual effect of enriching T lymphocytes CD8+ in solid tumors and targeting the destruction of the inner wall of tumor blood vessels. While killing tumor cells by cytotoxic T lymphocyte antigen CD8+, the stilbenes cut off the blood supply to tumor tissues, cause rapid necrosis in solid tumors, greatly improve the killing effects on tumors, and inhibit tumor metastasis. Thereby, they can be used to prepare anti-tumor medicaments, and also used in combination with tumor immunotherapeutics to achieve synergistic anti-tumor effects. In addition, the stilbene compounds of the present invention can inhibit the growth of ocular surface blood vessels and be used in the preparation of medicaments for treating various eye diseases. The stilbene compounds of the present invention have good application prospects.
Bibliography:Application Number: EP20230198589